Secondary-type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1.
Wright MF, Pozdnyakova O, Hasserjian RP, Aggarwal N, Shaver AC, Weinberg OK, Irlmeier R, Koyama T, Seegmiller AC, Strickland SA, Mason EF.
Wright MF, et al. Among authors: koyama t.
Am J Hematol. 2022 Dec;97(12):E462-E465. doi: 10.1002/ajh.26730. Epub 2022 Sep 30.
Am J Hematol. 2022.
PMID: 36106410
Free article.
No abstract available.